Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Eli Lilly (NYSE: LLY) stock has had plenty of good trading sessions over the past year or so, but Monday's sure wasn't among them. The storied pharmaceutical company's shares lost nearly 5% of ...

Like many pharma stocks, Eli ... Lilly is able to commercialize a new weight loss product in the next few years, it could reinforce its leadership in the market. Considering Lilly's growth, the ...

Eli Lilly (NYSE: LLY) stock has had plenty of good trading sessions over the past year or so, but Monday's sure wasn't among ...

Eli Lilly (LLY) closed the latest trading day at $822.27, indicating a -0.22% change from the previous session's end. This change lagged the S&P 500's daily gain of 0.49%. Elsewhere, the Dow lost ...

Like many pharma stocks, Eli Lilly (NYSE ... dominate the market. All of this has helped Lilly's revenue climb in the double digits in recent quarters and the stock price to take off.

We recently published a list of 12 Best Quality Stocks to Invest in Now. In this article, we are going to take a look at ...

The market is evolving from GLP-1s to GLP-1/GIPs, to so-called triple Gs (GLP1/GIP/glucagon) like Eli Lilly’s tirzepatide ... Analyst’s Disclosure: I/we have no stock, option or similar ...